The global market for AAV Vector CDMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
AAV (Adeno-Associated Virus) vector CDMO service refers to a service provided by biotechnology companies in the field of gene therapy and vaccine development, providing customers with comprehensive technical support from AAV vector construction, production to purification. By using AAV vector CDMO services, customers can focus on the core scientific issues of gene therapy and vaccine development, while handing over the production and quality control of AAV vectors to professional service providers, thereby accelerating product research and development. and listing process.
Adeno-associated virus (AAV) belongs to the family Parvoviridae, and its genome is approximately 4.8 kb of single-stranded DNA, non-enveloped. Only with the help of helper viruses such as adenovirus or herpesvirus, the host can produce infectious AAV (adeno-associated virus).
The recombinant adeno-associated virus vector (rAAV) used in the research field is a gene vector modified from non-pathogenic wild-type AAV. There are multiple serotypes of AAV. The main difference between AAV vectors of different serotypes is the capsid protein. The protein structures of different capsid proteins bind to different extracellular receptor molecules, so different serotypes have different targeting affinities to tissues or organs. Generally speaking, AAV has 12 serotypes and more than 100 variants. Due to its high safety, low immunogenicity, and long expression cycle, AAV is known as the most suitable tool for studying gene function in vivo.
This report aims to provide a comprehensive presentation of the global market for AAV Vector CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AAV Vector CDMO Services.
The AAV Vector CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AAV Vector CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AAV Vector CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology
Segment by Type
Adherent Culture
Suspension Culture
Segment by Application
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AAV Vector CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AAV Vector CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adherent Culture
1.2.3 Suspension Culture
1.3 Market by Application
1.3.1 Global AAV Vector CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Vaccine Development
1.3.3 Gene Therapy
1.3.4 Academic Scientific Research Institution
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AAV Vector CDMO Services Market Perspective (2020-2031)
2.2 Global AAV Vector CDMO Services Growth Trends by Region
2.2.1 Global AAV Vector CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AAV Vector CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 AAV Vector CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 AAV Vector CDMO Services Market Dynamics
2.3.1 AAV Vector CDMO Services Industry Trends
2.3.2 AAV Vector CDMO Services Market Drivers
2.3.3 AAV Vector CDMO Services Market Challenges
2.3.4 AAV Vector CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AAV Vector CDMO Services Players by Revenue
3.1.1 Global Top AAV Vector CDMO Services Players by Revenue (2020-2025)
3.1.2 Global AAV Vector CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global AAV Vector CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AAV Vector CDMO Services Revenue
3.4 Global AAV Vector CDMO Services Market Concentration Ratio
3.4.1 Global AAV Vector CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AAV Vector CDMO Services Revenue in 2024
3.5 Global Key Players of AAV Vector CDMO Services Head office and Area Served
3.6 Global Key Players of AAV Vector CDMO Services, Product and Application
3.7 Global Key Players of AAV Vector CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AAV Vector CDMO Services Breakdown Data by Type
4.1 Global AAV Vector CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global AAV Vector CDMO Services Forecasted Market Size by Type (2026-2031)
5 AAV Vector CDMO Services Breakdown Data by Application
5.1 Global AAV Vector CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global AAV Vector CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AAV Vector CDMO Services Market Size (2020-2031)
6.2 North America AAV Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AAV Vector CDMO Services Market Size by Country (2020-2025)
6.4 North America AAV Vector CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AAV Vector CDMO Services Market Size (2020-2031)
7.2 Europe AAV Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AAV Vector CDMO Services Market Size by Country (2020-2025)
7.4 Europe AAV Vector CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AAV Vector CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific AAV Vector CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AAV Vector CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific AAV Vector CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AAV Vector CDMO Services Market Size (2020-2031)
9.2 Latin America AAV Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AAV Vector CDMO Services Market Size by Country (2020-2025)
9.4 Latin America AAV Vector CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AAV Vector CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa AAV Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AAV Vector CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa AAV Vector CDMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific AAV Vector CDMO Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in AAV Vector CDMO Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza AAV Vector CDMO Services Introduction
11.2.4 Lonza Revenue in AAV Vector CDMO Services Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent AAV Vector CDMO Services Introduction
11.3.4 Catalent Revenue in AAV Vector CDMO Services Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River AAV Vector CDMO Services Introduction
11.4.4 Charles River Revenue in AAV Vector CDMO Services Business (2020-2025)
11.4.5 Charles River Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck AAV Vector CDMO Services Introduction
11.5.4 Merck Revenue in AAV Vector CDMO Services Business (2020-2025)
11.5.5 Merck Recent Development
11.6 SK pharmteco
11.6.1 SK pharmteco Company Details
11.6.2 SK pharmteco Business Overview
11.6.3 SK pharmteco AAV Vector CDMO Services Introduction
11.6.4 SK pharmteco Revenue in AAV Vector CDMO Services Business (2020-2025)
11.6.5 SK pharmteco Recent Development
11.7 Oxford Biomedica
11.7.1 Oxford Biomedica Company Details
11.7.2 Oxford Biomedica Business Overview
11.7.3 Oxford Biomedica AAV Vector CDMO Services Introduction
11.7.4 Oxford Biomedica Revenue in AAV Vector CDMO Services Business (2020-2025)
11.7.5 Oxford Biomedica Recent Development
11.8 AGC Biologics（MolMed）
11.8.1 AGC Biologics（MolMed） Company Details
11.8.2 AGC Biologics（MolMed） Business Overview
11.8.3 AGC Biologics（MolMed） AAV Vector CDMO Services Introduction
11.8.4 AGC Biologics（MolMed） Revenue in AAV Vector CDMO Services Business (2020-2025)
11.8.5 AGC Biologics（MolMed） Recent Development
11.9 Gene Universal
11.9.1 Gene Universal Company Details
11.9.2 Gene Universal Business Overview
11.9.3 Gene Universal AAV Vector CDMO Services Introduction
11.9.4 Gene Universal Revenue in AAV Vector CDMO Services Business (2020-2025)
11.9.5 Gene Universal Recent Development
11.10 Polyplus (Sartorius)
11.10.1 Polyplus (Sartorius) Company Details
11.10.2 Polyplus (Sartorius) Business Overview
11.10.3 Polyplus (Sartorius) AAV Vector CDMO Services Introduction
11.10.4 Polyplus (Sartorius) Revenue in AAV Vector CDMO Services Business (2020-2025)
11.10.5 Polyplus (Sartorius) Recent Development
11.11 CCRM
11.11.1 CCRM Company Details
11.11.2 CCRM Business Overview
11.11.3 CCRM AAV Vector CDMO Services Introduction
11.11.4 CCRM Revenue in AAV Vector CDMO Services Business (2020-2025)
11.11.5 CCRM Recent Development
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Details
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies AAV Vector CDMO Services Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in AAV Vector CDMO Services Business (2020-2025)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.13 Biovian
11.13.1 Biovian Company Details
11.13.2 Biovian Business Overview
11.13.3 Biovian AAV Vector CDMO Services Introduction
11.13.4 Biovian Revenue in AAV Vector CDMO Services Business (2020-2025)
11.13.5 Biovian Recent Development
11.14 Miltenyi Bioindustry
11.14.1 Miltenyi Bioindustry Company Details
11.14.2 Miltenyi Bioindustry Business Overview
11.14.3 Miltenyi Bioindustry AAV Vector CDMO Services Introduction
11.14.4 Miltenyi Bioindustry Revenue in AAV Vector CDMO Services Business (2020-2025)
11.14.5 Miltenyi Bioindustry Recent Development
11.15 Aldevron
11.15.1 Aldevron Company Details
11.15.2 Aldevron Business Overview
11.15.3 Aldevron AAV Vector CDMO Services Introduction
11.15.4 Aldevron Revenue in AAV Vector CDMO Services Business (2020-2025)
11.15.5 Aldevron Recent Development
11.16 Takara Bio
11.16.1 Takara Bio Company Details
11.16.2 Takara Bio Business Overview
11.16.3 Takara Bio AAV Vector CDMO Services Introduction
11.16.4 Takara Bio Revenue in AAV Vector CDMO Services Business (2020-2025)
11.16.5 Takara Bio Recent Development
11.17 Yposkesi
11.17.1 Yposkesi Company Details
11.17.2 Yposkesi Business Overview
11.17.3 Yposkesi AAV Vector CDMO Services Introduction
11.17.4 Yposkesi Revenue in AAV Vector CDMO Services Business (2020-2025)
11.17.5 Yposkesi Recent Development
11.18 Genezen
11.18.1 Genezen Company Details
11.18.2 Genezen Business Overview
11.18.3 Genezen AAV Vector CDMO Services Introduction
11.18.4 Genezen Revenue in AAV Vector CDMO Services Business (2020-2025)
11.18.5 Genezen Recent Development
11.19 Exthera
11.19.1 Exthera Company Details
11.19.2 Exthera Business Overview
11.19.3 Exthera AAV Vector CDMO Services Introduction
11.19.4 Exthera Revenue in AAV Vector CDMO Services Business (2020-2025)
11.19.5 Exthera Recent Development
11.20 GenScript ProBio
11.20.1 GenScript ProBio Company Details
11.20.2 GenScript ProBio Business Overview
11.20.3 GenScript ProBio AAV Vector CDMO Services Introduction
11.20.4 GenScript ProBio Revenue in AAV Vector CDMO Services Business (2020-2025)
11.20.5 GenScript ProBio Recent Development
11.21 EurekaBio
11.21.1 EurekaBio Company Details
11.21.2 EurekaBio Business Overview
11.21.3 EurekaBio AAV Vector CDMO Services Introduction
11.21.4 EurekaBio Revenue in AAV Vector CDMO Services Business (2020-2025)
11.21.5 EurekaBio Recent Development
11.22 Obio Technology
11.22.1 Obio Technology Company Details
11.22.2 Obio Technology Business Overview
11.22.3 Obio Technology AAV Vector CDMO Services Introduction
11.22.4 Obio Technology Revenue in AAV Vector CDMO Services Business (2020-2025)
11.22.5 Obio Technology Recent Development
11.23 GeneSail Biotech
11.23.1 GeneSail Biotech Company Details
11.23.2 GeneSail Biotech Business Overview
11.23.3 GeneSail Biotech AAV Vector CDMO Services Introduction
11.23.4 GeneSail Biotech Revenue in AAV Vector CDMO Services Business (2020-2025)
11.23.5 GeneSail Biotech Recent Development
11.24 VectorBuilder
11.24.1 VectorBuilder Company Details
11.24.2 VectorBuilder Business Overview
11.24.3 VectorBuilder AAV Vector CDMO Services Introduction
11.24.4 VectorBuilder Revenue in AAV Vector CDMO Services Business (2020-2025)
11.24.5 VectorBuilder Recent Development
11.25 WuXi ATU
11.25.1 WuXi ATU Company Details
11.25.2 WuXi ATU Business Overview
11.25.3 WuXi ATU AAV Vector CDMO Services Introduction
11.25.4 WuXi ATU Revenue in AAV Vector CDMO Services Business (2020-2025)
11.25.5 WuXi ATU Recent Development
11.26 Ubrigene
11.26.1 Ubrigene Company Details
11.26.2 Ubrigene Business Overview
11.26.3 Ubrigene AAV Vector CDMO Services Introduction
11.26.4 Ubrigene Revenue in AAV Vector CDMO Services Business (2020-2025)
11.26.5 Ubrigene Recent Development
11.27 Porton Biologics
11.27.1 Porton Biologics Company Details
11.27.2 Porton Biologics Business Overview
11.27.3 Porton Biologics AAV Vector CDMO Services Introduction
11.27.4 Porton Biologics Revenue in AAV Vector CDMO Services Business (2020-2025)
11.27.5 Porton Biologics Recent Development
11.28 Pharmaron
11.28.1 Pharmaron Company Details
11.28.2 Pharmaron Business Overview
11.28.3 Pharmaron AAV Vector CDMO Services Introduction
11.28.4 Pharmaron Revenue in AAV Vector CDMO Services Business (2020-2025)
11.28.5 Pharmaron Recent Development
11.29 PackGene Biotechnology
11.29.1 PackGene Biotechnology Company Details
11.29.2 PackGene Biotechnology Business Overview
11.29.3 PackGene Biotechnology AAV Vector CDMO Services Introduction
11.29.4 PackGene Biotechnology Revenue in AAV Vector CDMO Services Business (2020-2025)
11.29.5 PackGene Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology
Ìý
Ìý
*If Applicable.
